{"id":"tp-46465","type":"article-newspaper","title":"uniQure Says FDA Grants Priority Review to Huntington’s Gene Therapy","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/46465","datePublished":"2026-11-02T13:31:15.000Z","dateModified":"2026-11-02T13:31:15.000Z","language":"en","abstract":"The application seeks accelerated approval, and the company plans to begin U.S. screening for a 200-patient confirmatory trial by the end of 2026.","section":"Regulation","references":[]}